Fears that insurers would sell cheaper, “bare bones” plans to attract healthy enrollees away from the Affordable Care Act (ACA)’s marketplaces and shift sicker, more costly enrollees into the ACA plans have been unfounded.
Fears that insurers would sell cheaper, “bare bones” plans to attract healthy enrollees away from the Affordable Care Act (ACA)’s marketplaces and shift sicker, more costly enrollees into the ACA plans have been unfounded, according to a new report from The Commonwealth Fund. The report compared 2 segments of the individual health insurance market: plans sold on the ACA marketplaces and those sold outside the marketplaces through insurers or brokers.
Researchers Michael J. McCue and Mark A. Hall found that insurers increasingly are selling more of their individual health insurance plans in the ACA marketplaces. Individual plans sold outside of the ACA marketplaces had larger premium increases and had higher administrative costs.
The data used for the study come from the unified rate review template spreadsheets for 2016 that insurers must file with the Center for Consumer Information and Insurance Oversight. Data were from 543 unique insurers in different states.
The study found that in 2016, 17% of individual health insurance plans are being sold exclusively outside the marketplaces, a 28% drop from 2014. Insurers projected that in 2016 there would be 12.8 million people enrolled in plans sold mainly through the ACA marketplace and 2.6 million in off-marketplace plans. Insurers had projected in 2014 that 11.1 million people would enroll in marketplace plans and 4.2 million would enroll in off-marketplace plans.
The report states that the bronze level plans, the least expensive plans that provide the lowest amount of coverage, are equally popular on and off the marketplaces. The gold and platinum plans, which are the most expensive and provide the most coverage, are much more prevalent off the marketplaces.
The report found that:
The data make a strong case for the viability of the ACA marketplaces, according to Sara Collins, the Commonwealth Fund’s vice president for health care coverage and access.
“Insurers inside the marketplaces appear to be competing well on price and continue to sell more of their business through them,” she said in a statement. “And the measures designed to encourage insurers to enroll healthier as well as sicker people in the marketplaces are working.”
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
The Pivotal Role of Payers in Improving Health Equity, Maternal Health Care in the US
March 26th 2024A presentation at the Greater Philadelphia Business Coalition on Health's 2024 Women’s Health Summit discussed how payers, including employers and public entities, can strategically influence health care purchasing to prioritize maternal health and equity.
Read More
What We’re Reading: HHS' Funding Flat; Mifepristone Safety; Insulin Shortage
March 25th 2024Flat funding for Health and Human Services (HHS) leaves critical health initiatives stagnant; Supreme Court weighs tightening regulations on abortion pill; manufacturing delay sparks access concerns for insulin medication.
Read More